<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M580</article-id>
      <article-id pub-id-type="publisher-id">molbank-2008-M580</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synthesis of 5-benzyl-2,6-dimethylpyridazin-3(2<italic>H</italic>)-one</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Benchat</surname>
            <given-names>Nour-Eddine</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Benalla</surname>
            <given-names>Abderazak</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>El Kalai</surname>
            <given-names>Fouad</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramdani</surname>
            <given-names>Mohammed</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Daoui</surname>
            <given-names>Said</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2008-M580">Laboratory of Chemistry applied and environment, University Mohamed I, Sciences Faculty, 60000 Oujda, Morocco</aff>
      <author-notes>
        <corresp id="c1-molbank-2008-M580"><label>*</label> Author to whom correspondence should be addressed; E-mai: <email>n_benchat@yahoo.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>11</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>11</month>
        <year>2008</year>
      </pub-date>
      <volume>2008</volume>
      <issue>3</issue>
      <elocation-id>M580</elocation-id>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>09</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>11</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2008 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <license>
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Pyridazines</kwd>
        <kwd>alkylation</kwd>
        <kwd>microwave</kwd>
        <kwd>anticancer activity</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Recentely, Rubat <italic>et al.</italic> [<xref ref-type="bibr" rid="B1-molbank-2008-M580">1</xref>] synthesized a series of products by alkylation of pyridazines, the authors showed that these products are good analgesics and have a low toxicity. In our ongoing reseach program, we have synthesized compound (<bold>II</bold>); it will be subjected to further pharmacological investigations, especially tests of its anticancer activity.</p>
	  <disp-formula id='molbank-2008-M580-i001'>
        <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M580-i001.tif"/>
		</disp-formula>
      <p>The product (<bold>II</bold>) was prepared from 5-benzyl-6-methylpyridazin-3(2<italic>H</italic>)-one (<bold>I</bold>) by solid-liquid PTC conditions without solvent [<xref ref-type="bibr" rid="B2-molbank-2008-M580">2</xref>]. To pyridazinone (<bold>I</bold>) (1.2 g, 5 mmol) were added potassium carbonate  (0.692 g, 5 mmol), TBAB (0.3 g, 1 mmol) and methyl iodide (0.73 g, 5 mmol). The mixture was placed in a pyrex tube which was then introduced into a Maxidigest MX 350 Prolabo microwave monomode reactor, fitted with a rotational system. At the end of the irradiation time (10 min, 90 W irradiation power), the mixture was cooled to ambient temperature. The precipitate formed was filtered and washed with water, yield: 96% of (<bold>II</bold>).</p>
      <p>Melting point: 89-93&#xB0;C</p>
      <p>IR (KBr): 1663 (CO), 1591 (C=N), 1430, 1495 (C=C).</p>
      <p><sup>1</sup>H NMR (300.14 MHz, CDCl<sub>3</sub>): &#x3B4; (ppm) : 2.20 (s, 3H, CH<sub>3</sub>), 3.72 (s, 3H, CH<sub>3</sub>), 3.81 (s, 2H, CH<sub>2</sub>), 6.53 (s, 1H, H-4), 7.25 (m, 5H, aromatic protons). </p>
      <p><sup>13</sup>C NMR (75.48 MHz, CDCl<sub>3</sub>): &#x3B4; (ppm) 19.12 (CH<sub>3</sub>), 35.85 (CH<sub>2</sub>), 39.67 (NCH<sub>3</sub>), 127.66 (CH<sub>aromatic</sub>), 127.87 (CH<sub>aromatic</sub>), 129.32 (2 CH<sub>aromatic</sub>), 129.51 (2 CH<sub>aromatic</sub>), 135.66, 145.25, 146.52, 160.63 (C=O).</p>
      <p>Anal. Calcd for  C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O: %C: 72.89; %H: 6.54;; %N: 13.08. Found: %C: 72.47; %H: 6.43; %N: 12.72.</p>
  </body>
  <back>
    <app-group>
    <app id="app1-molbank-2008-M580">
       <title>Supplementary materials</title>
       <supplementary-material id="molbank-2008-M580-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M580-s001-mod.mol">
	   <label>Supplementary File 1</label>
	   </supplementary-material>
	   <supplementary-material id="molbank-2008-M580-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M580-s001.mol">
	   <label>Supplementary File 2</label>
	   </supplementary-material>
	</app>
	</app-group>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2008-M580">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubat</surname>
              <given-names>C.G.</given-names>
            </name>
            <name>
              <surname>Coudert</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Couquelet</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bastide</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bastide</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>Chem. Pharm. Bull.</source>
          <year>1988</year>
          <volume>36</volume>
          <fpage>1558</fpage>
          <pub-id pub-id-type="doi">10.1248/cpb.36.1558</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2008-M580">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De La Hoz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Diaz-Ortiz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <source>Chem. Soc. Rev.</source>
          <year>2005</year>
          <volume>34</volume>
          <fpage>164</fpage>
          <pub-id pub-id-type="doi">10.1039/B411438H</pub-id>
          <pub-id pub-id-type="pmid">15672180</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
